Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the reasons are for the most recent NHS England review of the pancreatic cancer drug available on the national Cancer Drugs Fund.
The Cancer Drugs Fund panel considered a number of drug/indications for reprioritisation in July 2015. The panel’s decisions were announced on 4 September 2015 and are available at:
www.england.nhs.uk/ourwork/pe/cdf/cdf-drug-sum/